| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/17/2003 | WO2002022805A3 Modulation of il-2- and il-15-mediated t cell responses |
| 07/17/2003 | WO2002017858A9 Role of fosb in bone formation |
| 07/17/2003 | WO2002011713A3 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 07/17/2003 | US20030134901 Lipoxin compounds and their use in treating cell proliferative disorders |
| 07/17/2003 | US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc. |
| 07/17/2003 | US20030134876 Inhibiting TNF alpha |
| 07/17/2003 | US20030134874 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease |
| 07/17/2003 | US20030134850 Hydrazinyl and nitrogen oxide pyrazoles |
| 07/17/2003 | US20030134849 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors |
| 07/17/2003 | US20030134840 Novel compounds |
| 07/17/2003 | US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles |
| 07/17/2003 | US20030134836 Substituted arylamine derivatives and methods of use |
| 07/17/2003 | US20030134829 X is a ring having at least 4 atoms in the ring; K is hydrocarbyl group; Rh1 is an optional halo group; Rh2 is an optional halo group; at least one of Rh1 and Rh2 is present; Rs is any one of a sulphamate group, a phosphonate, |
| 07/17/2003 | US20030134810 Delivery of pharmacologically active agents associated with polymeric biocompatible materials. Compositions comprising a first, negatively charged pharmacologically active agent such as an oligonucleotide and a polycationic polymer such as |
| 07/17/2003 | US20030134792 Compositions and methods for treating articular cartilage disorders |
| 07/17/2003 | US20030134430 Novel amino acid sequences for human caenorhabditis elegans-like protein polypeptides |
| 07/17/2003 | US20030133930 Administering to a patient having an autoimmune disorder an antibody to a B-cell antigens and a carrier; CD22, CD20, CD19, and CD74 or HLA-DR antigen. |
| 07/17/2003 | US20030133880 Powdery pharmaceutical compositions for inhalation |
| 07/17/2003 | US20030133875 Assay for screening candidate drug for the treatment of inflammatory diseases and methods for treating the same |
| 07/17/2003 | CA2767061A1 Specific binding agents of human angiopoietin-2 |
| 07/17/2003 | CA2472647A1 Mammal prolactin variants |
| 07/17/2003 | CA2472585A1 Drug mixture with enhanced dissolution rate |
| 07/17/2003 | CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists |
| 07/17/2003 | CA2472111A1 Human mast cell-expressed membrane proteins |
| 07/17/2003 | CA2472049A1 Dominant negative proteins and methods thereof |
| 07/17/2003 | CA2471951A1 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
| 07/17/2003 | CA2471938A1 Agent for treating arthritis |
| 07/17/2003 | CA2471932A1 A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer |
| 07/17/2003 | CA2471490A1 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | CA2470495A1 Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 07/16/2003 | EP1327449A1 Remedies for ischemic diseases |
| 07/16/2003 | EP1326980A2 Methods of treatment using wisp polypeptides |
| 07/16/2003 | EP1326978A2 Hematopoietin receptors hpr1 and hpr2 |
| 07/16/2003 | EP1326967A2 Novel aggrecanase molecules |
| 07/16/2003 | EP1326896A2 Human anti-cd40 antibodies |
| 07/16/2003 | EP1326894A2 Novel tumor-associated marker |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 07/16/2003 | EP1326859A1 Quinazoline derivatives with anti-tumour activity |
| 07/16/2003 | EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists |
| 07/16/2003 | EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 07/16/2003 | EP1326853A1 New thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors |
| 07/16/2003 | EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 07/16/2003 | EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use |
| 07/16/2003 | EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis |
| 07/16/2003 | EP1326829A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 07/16/2003 | EP1326654A2 Methods and compositions for tissue regeneration |
| 07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
| 07/16/2003 | EP1326626A2 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 07/16/2003 | EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 07/16/2003 | EP1326618A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases |
| 07/16/2003 | EP1326615A1 Phosphoric acid salt of an integrin receptor antagonist |
| 07/16/2003 | EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 07/16/2003 | EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS |
| 07/16/2003 | EP1326591A2 Combination of statins and sorbitol dehydrogenase inhibitors |
| 07/16/2003 | EP1235579B1 Pharmaceutical compositions comprising trimegestone |
| 07/16/2003 | EP1181284B1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 07/16/2003 | EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/16/2003 | EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1 |
| 07/16/2003 | EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 07/16/2003 | CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 07/16/2003 | CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists |
| 07/16/2003 | CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha |
| 07/16/2003 | CN1430597A Novel MMP-2/MMP-9 inhibitors |
| 07/16/2003 | CN1430512A Modulation of bone formation |
| 07/16/2003 | CN1430505A Microspheres for active embolization |
| 07/16/2003 | CN1429834A Fructus gleditsiae total saponin, its preparation method and use in preparation of medicine |
| 07/16/2003 | CN1429616A New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method |
| 07/16/2003 | CN1429579A Massaging cream for relaxing muscles and tendons and its preparation method |
| 07/16/2003 | CN1114604C Bicyclic aryl carboxamides and their therapeutic use |
| 07/16/2003 | CN1114597C Quinoline derivs |
| 07/16/2003 | CN1114420C Medicine for treating intractable ischias and chronic lumbocrural pain and its preparing process |
| 07/16/2003 | CN1114419C Application of Radix Polygoni Multiflori and its extract in preventing and treating osteoporosis |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/15/2003 | US6593472 NK-1 receptor active amine oxide prodrugs |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/15/2003 | US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. |
| 07/15/2003 | US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery |
| 07/15/2003 | US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/15/2003 | US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 07/15/2003 | US6593345 Naphthyl compounds, intermediates, compositions, and methods of use |
| 07/15/2003 | US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man. |
| 07/15/2003 | US6593322 Compounds and methods for modulation of estrogen receptors |
| 07/15/2003 | US6593310 Add to a mammal in need of such treatment an effective amount, typically in the range of 0.1 to 100 micrograms per kg of body weight, of a compound capable of maintaining the integrity of connective tissue, for example pentosan polysulfate. |
| 07/15/2003 | US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization |
| 07/15/2003 | US6593109 Culturing cells containing DNA sequences under the control of a regulatory sequence capable of directing expression; useful in treating bone defects, healing bone injury and wounds |
| 07/15/2003 | US6593108 Nucleic acid molecule encoding a melanin-concentrating hormone receptor 2 polypeptide |
| 07/15/2003 | US6592868 Produced by hybridoma having ATCC Accession Number HB 10916 |